Murchinson Ltd. Oramed Pharmaceuticals Inc. Transaction History
Murchinson Ltd.
- $566 Million
- Q2 2024
A detailed history of Murchinson Ltd. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Murchinson Ltd. holds 1,699,990 shares of ORMP stock, worth $3.94 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
1,699,990
Previous 874,992
94.29%
Holding current value
$3.94 Million
Previous $2.25 Million
94.31%
% of portfolio
0.77%
Previous 0.48%
Shares
4 transactions
Others Institutions Holding ORMP
# of Institutions
61Shares Held
6.36MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN1.35MShares$3.13 Million2.47% of portfolio
-
Boothbay Fund Management, LLC New York, NY825KShares$1.91 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$850,0502.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$672,3420.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny259KShares$601,1120.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...